CAPITAL

• Research type

  Research Study

• Full title

  A dose finding study evaluating the safety and tolerability of Capecitabine and Aflibercept in patients with unresectable metastatic colorectal cancer deemed unsuitable for doublet/ triplet chemotherapy.

• IRAS ID

  136600

• Contact name

  Paul Ross

• Contact email

  paul.ross@gstt.nhs.uk

• Sponsor organisation

  Guy's and St Thomas' NHS Foundation Trust

• Eudract number

  2013-002308-15

• ISRCTN Number

  No ISRCTN

• Clinicaltrials.gov Identifier

  No NCT

• REC name

  East of England - Essex Research Ethics Committee

• REC reference

  13/EE/0343

• Date of REC Opinion

  11 Oct 2013

• REC opinion

  Favourable Opinion